{
  "id": 16679711,
  "title": "Design of full-length agonist and antagonist antibodies for hard targets",
  "url": "https://urgent.news/2026/10/26/design-of-full-length-agonist-and-antagonist-antibodies-for-hard",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-26T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.10.21.760573v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Therapeutic antibodies have transformed modern medicine, yet conventional discovery relies on lengthy experimental workflows, offers limited control over how antibodies engage their targets, and struggles to deliver candidates across many important target classes. Despite recent advances in computational protein design, generating full-length antibodies with desired functional activity and…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}